Skip to main content
TipRanks
Go Ultimate75% OFF

PTC Therapeutics (P91) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

P91 Analyst Ratings

Strong Buy
12Ratings
10Buy2Hold0Sell
Based on 12 analysts giving stock ratings to PTC Therapeutics in the past 3 months

P91 Stock 12 Month Forecast

CHF84.08▲(0.00% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for PTC Therapeutics in the last 3 months. The average price target is CHF 84.08 with a high forecast of CHF 115.18 and a low forecast of CHF 52.13. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF115.18Average Price TargetCHF84.08Lowest Price TargetCHF52.13

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:P91
Price TargetArticle
J.P. MorganCHF77.35buy―Reiterated11/05/26
BarclaysCHF102.57buy―Reiterated11/02/26
CitiCHF90.80→CHF91.64buy―Reiterated11/02/26
UBSCHF75.67buy―Reiterated10/30/26
Wells FargoCHF91.64→CHF94.16buy―Reiterated10/30/26
TD CowenCHF75.67→CHF79.87buy―Reiterated10/30/26
Bank of America Securities―buy―Reiterated10/30/26
RBC CapitalCHF63.06→CHF64.74hold―Reiterated10/29/26
Cantor FitzgeraldCHF115.18buy―Reiterated10/29/26
Raymond JamesCHF90.80→CHF89.12buy―Reiterated10/20/26
Truist Financial Analyst forecast on CH:P91Alex NackenoffNot RankedTruist FinancialCHF52.13hold―Initiated10/16/26
Leerink PartnersCHF58.85→CHF82.39buy―Initiated09/14/26
Morgan StanleyCHF78.19→CHF87.44buy―Reiterated07/31/26
Goldman SachsCHF58.85sell―Reiterated07/30/26
JefferiesCHF63.90→CHF71.46buy―Upgraded05/27/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
SLDBSolid Biosciences
RDNTRadnet
PTGXProtagonist Therapeutics
HROWHarrow Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering PTC Therapeutics

3 Months
Tiago Fauth
Tiago FauthRaymond James
Success Rate13/18 ratings generated profit
72%
Average Return
+15.01%

Copying Tiago Fauth's trades and holding each position for 3 Months would result in 72.22% of your transactions generating a profit, with an average return of +15.01% per trade.

1 Year
Tiago Fauth
Tiago FauthRaymond James
Success Rate15/18 ratings generated profit
83%
Average Return
+46.40%

Copying Tiago Fauth's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +46.40% per trade.

2 Years
Sami Corwin
Sami CorwinWilliam Blair
Success Rate23/27 ratings generated profit
85%
Average Return
+60.08%

Copying Sami Corwin's trades and holding each position for 2 Years would result in 85.19% of your transactions generating a profit, with an average return of +60.08% per trade.

P91 Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for P91
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy79111413
Buy14101065
Hold53333
Sell11100
Strong Sell00000
total2723252321

In the current month, P91 has received 18 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. P91 average Analyst price target in the past 3 months is 84.08.

P91 Financial Forecast

CHF-3CHF-2CHF-1CHF0CHF1Q1 2026Q3 2026Q4 2026
HighCHF0.74
ConsensusCHF0.28
LowCHF-0.35

P91 Earnings Forecast

Next quarter’s earnings estimate for P91 is CHF 0.28 with a range of -CHF 0.35 to CHF 0.74. The previous quarter’s EPS was -CHF 0.51. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF135MCHF175.1MCHF215.3MCHF255.4MCHF295.5MQ1 2026Q3 2026Q4 2026
HighCHF285M
ConsensusCHF271M
LowCHF249M

P91 Sales Forecast

Next quarter’s sales forecast for P91 is CHF 270.83M with a range of CHF 248.61M to CHF 285.27M. The previous quarter’s sales results were CHF 293.31M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

P91 Stock Forecast FAQ

What is CH:P91’s average 12-month price target, according to analysts?
Based on analyst ratings, PTC Therapeutics’s 12-month average price target is CHF84.08.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PTC Therapeutics a Buy, Sell or Hold?
PTC Therapeutics has a consensus rating of Strong Buy, which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
What is PTC Therapeutics’s share price target?
The average share price target for PTC Therapeutics is CHF84.08. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF115.18, and the lowest forecast is CHF52.13. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about PTC Therapeutics?
PTC Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of PTC Therapeutics?
To buy shares of CH:P91, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.